International 2

Download as pdf or txt
Download as pdf or txt
You are on page 1of 4

SM Journal of Sarcoma Research

Case Report © Green C. et al. 2021

Epithelioid Angiosarcoma in the Inguinal Canal


Region of an 81-year-old man. Case Report of a Rare
Tumor with Challenging Diagnosis and Review of the
Literature
Christian Green*, Malina Mohtadi, Joseph Russo, Brandon Watkins, Siovan Hope-Ross, Zachary
Elder, Jacqueline Nicholas, Mohamed Aziz
Department of Pathology- American University of the Caribbean, School of Medicine, USA

Abstract
Angiosarcomas, which are endothelial in origin, make up less than 1% of all soft tissue sarcomas. For every million people in the
United States, one will be diagnosed with an angiosarcoma. Most angiosarcomas are found in the breast, deep soft tissue of the head and
neck, and skin, though they may rarely arise within other soft tissue sites. Epithelioid angiosarcomas represent a diagnostically challenging
subset of angiosarcomas due to their non-specific imaging features, non-specific clinical presentation and rarity of the neoplasm. Epithelioid
angiosarcomas should always be included in the differential diagnosis in patients with vascular neoplasms. Early detection combined with
complete resection of the mass, as well as adjuvant therapy if possible, yields the highest favorable prognosis for patients with EAs.

Keywords: Epithelioid, angiosarcoma, carcinoma, Immunohistochemistry, vascular

ABBREVIATION [8]. Angiosarcomas can develop at any age, however the median
age is reported to be between 60 and 71 years old [15,12]. The
EA: Epithelioid angiosarcoma, AS: Angiosarcoma, IHC: head and neck account for the majority in location [16,12]. Risk
Immunohistochemistry, EM: electron microscopy factors for epithelioid angiosarcoma include toxic chemical
INTRODUCTION exposure, Thorotrast exposure, use of Dacron vascular grafts,
chronic lymphedema, and previous irradiation, though the
Angiosarcomas (ASs) are endothelial in origin and make etiology has not been completely confirmed [4]. Certain familial
up less than 1% of all soft tissue sarcomas [1,2]. Endothelial syndromes are associated with AS such as neurofibromatosis
malignancies are derived from mesenchymal origin, which can type-1, Maffucci syndrome, bilateral retinoblastoma, von
undergo blood vessel or lymphatic differentiation, though they Recklinghausen syndrome, hemochromatosis, and Klippel-
may follow both endothelial cell lines [26]. Trenaunay syndrome and appear with other lesions like port-
Classically, angiosarcomas develop in the breast, head, neck wine stains, and hemangiomas [11,17,10,18].
or skin of patients who are 60-70 years of age [1,12,15]. The EAs represent a problematic subset of endothelial neoplasms
range of primary sites is credited to the universality of lymphatics due to non-specific radiological signs of malignancy, as well as
and blood vessels throughout the body. Deep soft tissues have an ambiguous clinical presentation, rarity of the neoplasm, and
an extensive lymphovascular supply and thus are at the highest histomorphologic resemblance when compared to more prevalent
risk for developing ASs. Angiosarcomas vary and involve varied benign and malignant neoplasms. Immunohistochemistry (IHC)
patterns of growth, including spindled, papillary and epithelioid is paramount in diagnosing EA. In conjunction with IHC, electron
morphology [4]. Epithelioid angiosarcomas (EAs) typically form microscopy (EM) can provide further identifying information
spongy, hemorrhagic masses due to their vascular characteristics for EAs [23]. Patients usually experience pain and the presence
of a mass, followed by fever, weakness, and weight loss [7]. In
Submitted: 20 August, 2021 | Accepted: 12 September, 2021 | Published: some studies, up to one-third of patients with EA experience a
15 September, 2021 hypocoagulable state, including ecchymosis, gastrointestinal and
peritoneal bleeding, and persistent hematomas [10].
*Corresponding author(s): Christian Green, Department of Pathology,
American University of the Caribbean School of Medicine, 1 University Preventative measures for EA include avoiding Thorotrast
Drive at Jordan Road Cupecoy, St. Maarten, Tel: +16013071393
exposure or use of Dacron vascular grafts, though most patients
Copyright: © 2021 Green C, et al. This is an open-access article develop EA without an association with these risk factors [4].
distributed under the terms of the Creative Commons Attribution Complete resection is considered the current standard of care
License, which permits unrestricted use, distribution, and reproduction in in patients with EA, though the complexity of the small area of
any medium, provided the original author and source are credited.
the head and neck make negative margins difficult to achieve.
Citation: Green C, Mohtadi M, Russo J, Watkins B, Hope-Ross S, et Paclitaxel and Bevacizumab used in conjunction with surgical
al. (2021) Epithelioid Angiosarcoma in the Inguinal Canal Region of an intervention has been shown to improve prognosis [24,25]. We
81-year-old man. Case Report of a Rare Tumor with Challenging Diagnosis present a case of epithelioid angiosarcoma in the inguinal canal
and Review of the Literature. SM J Sarcoma Res 5: 4.
region in an 81-year-old man and we review the literature.

SM J Sarcoma Res 5 : 4 1/4


CASE PRESENTATION CK 5/6, 34 BE12, CK19, HMB45, S100, CD21, CD35, LCA (CD45),
SMA, PAX-2, B-Catenin, CD34, WT-1, CD68, and CD99. Additional
An 81-year-old man presented with a large painful soft tissue negative IHC studies included Desmin, H-Caldesmon, Myogenin,
mass at the left inguinal region. He also reported a weight loss PLAP, AFB, CD138, PSA, Synaptophysin and Chromogranin.
of 15 Ib during the year before current presentation. Physical This negative IHC studies were sufficient to rule out epithelial,
examination noted two adjacent large soft tissue masses in the myoepithelial, lymphoid, dendritic, histiocytic, mesothelial or
left groin region. CT scan studies revealed two soft tissue masses melanocytic origin. The tumor cells were, however, strongly and
with irregular enhancement and decreased heterogeneous diffusely positive for Vimentin, which in absence of other specific
density infiltrating the surrounding soft tissue structures. markers supported mesenchymal origin of the tumor. As muscle
MRI scan demonstrated a heterogeneous enhancement of and neural mesenchymal origin were also ruled out, vascular IHC
the two masses, with ill-defined demarcation with infiltrated markers were tested. The tumor cells were strongly positive for
surrounding structures and non-enhanced necrosis inside the CD31, Fli-1, and Cytokeratin AE1/AE3 (Focal scattered positive
lesions. Patient reported history of controlled type-II diabetes, cells), in addition to Vimentin (Figure 1 D-E-F).
controlled hypertension and controlled hypercholesterolemia.
The tumor masses measured 5.5x 3.5x 3 cm and 4X 3x 2.5 cm. The histomorphologic features and the IHC profile were
He also reported localized prostatic adenocarcinoma treated by consistent with the diagnosis of epithelioid angiosarcoma in the
prostatectomy 10 years prior to current presentation. Inguinal canal region. Patient underwent staging investigations,
and none were shown to have distant metastasis. The case
A fine needle aspiration and core biopsy were obtained was discussed in a multidisciplinary tumor board and it was
from the larger inguinal mass. Microscopic examination recommended to undergo total surgical excision followed by
demonstrated a tumor composed of solid sheets of high- adjuvant radiotherapy. Patient refused surgery or radiation
grade pleomorphic epithelioid neoplastic cells with abundant therapy and chemotherapy was initiated with six courses of
amphophilic to lightly eosinophilic cytoplasm, large vesicular combination chemotherapy with paclitaxel, epirubicin and
nuclei, and prominent nucleoli. The tumor was set in fibrotic carboplatin. Patient tolerated the treatment well and showed no
stroma with scattered complex anastomosing vascular channels evidence of recurrence or metastasis for 8 months after which he
and abundant abnormal mitosis exceeding 15 mitosis/10 HPF. was lost to follow up.
Prominent tumor necrosis was also noted (Figure 1 A-B-C). The
histomorphologic features were non-specific and could be seen DISCUSSION
in various carcinomas, epithelioid variants of mesenchymal
Angiosarcomas, which are endothelial in origin, make up
tumors, anaplastic tumors as well as other malignant tumors.
less than 1% of all soft tissue sarcomas.1,2 Angiosarcomas have
Although the tumor displayed prominent epithelioid features,
a propensity for breast, deep soft tissue of the head and neck,
immunohistochemistry studies were essential to determine the
and skin, accounting for 5.4% of all skin sarcomas.1,3 Rarely,
line of cell differentiation. The tumor cells were negative for
angiosarcomas may arise within other soft tissue malignancies.6
numerous lineage specific markers including Cam5.2, EMA, P63,

Figure 1 Histomorphology and immunohistochemistry profile of the excised angiomatoid angiosarcoma


1A: The tumor is set in fibrotic stroma with scattered complex anastomosing vascular channels (H&E stain X20 magnification)
1B: Low power view of the tumor showing masses of cellular epithelioid tumor cells (H&E stain X40 magnification)
1C: High power view of the tumor showing high-grade pleomorphic epithelioid neoplastic cells with abundant amphophilic to lightly eosinophilic
cytoplasm, large vesicular nuclei, prominent nucleoli and multiple abnormal mitosis (H&E stain X60)
1D: Tumor cells positive for Vimentin
1E: Tumor cells positive for CD-31
1F: Tumor cells positive for Fli-1

SM J Sarcoma Res 5: 4 2/4


EAs can resemble many types of neoplasms: metastatic is found to have a 5-year survival rate ranging from 12%-35%
melanoma, anaplastic large cell lymphoma, epithelioid sarcoma, [19,12]. The overall mean survival was seen to be 36 months
epithelioid hemangioma, epithelioid hemangioendothelioma, with adjuvant radiotherapy versus a 9 months survival without
metastatic carcinoma, proximal-type epithelioid sarcoma, adjuvant therapy [20,12]. This case report and literature review
epithelioid rhabdomyosarcoma and epithelioid-variant seek to shed light on the variability and diagnostic challenges
nerve sheath tumors. Low grade EA tumors often resemble a in patients with epithelioid angiosarcoma. The non-specific
hemangioma, and high grade EA tumors may appear as various radiological signs of malignancy, as well as an ambiguous clinical
anaplastic neoplasms [14,10,12]. On contrast CT soft tissue EA presentation, rarity of the neoplasm, and histomorphologic
can be seen as an irregular enhanced mass, occasionally with resemblance when compared to more prevalent benign and
underlying bone or organ invasion [13,12]. EA tumors, such as malignant neoplasms pose a threat to epithelioid angiosarcomas
those in the soft tissue of the extremities, abdomen, chest wall, being mis-diagnosed. The definitive diagnosis of EA is made
and peritoneum or retroperitoneum are found to display differing through biopsy and meticulous evaluation through histological
characteristics [10,12]. EAs in the extremities are fast growing and specific immunohistochemical analysis, and possibly EM
and palpable, compared to those in the peritoneum which studies. Epithelioid angiosarcomas should always be included in
are associated with increased pain due to mass effect [11,12]. the differential diagnosis in patients with vascular neoplasms.
Epithelioid hemangiomas are generally found in a younger
patients, usually does not express factor VIII, and demonstrates
ACKNOWLEDGMENT
normal nuclei well-formed vascularity, demonstrating its benign Special thanks to Grecia Corrada, Jacob Selph, and Lorenzo
nature.21 Negative staining for S-100 and HMB-45 excludes Russo, MD candidates, American University of the Caribbean for
melanoma from the differential diagnosis.4 Carcinoma will not their assistance in reviewing the final version of this manuscript.
stain positive for endothelial markers, including CD31, CD34,
Fli-1 or factor VIII. Anaplastic large cell lymphomas express REFERENCES
lymphocytic antigens, such as CD45 and CD30, which are absent 1. McAdam JA, Stewart F, Reid R. Vaginal epithelioid angiosarcoma. J Clin
in most EAs.21 Malignant nerve sheath tumors do not stain Pathol. 1998;51(12):928-930. doi:10.1136/jcp.51.12.928
with vascular markers and will be S-100 positive.4 Analysis of 2. Weishaupt J, Miller J, Oehler MK. Vaginal epithelioid angiosarcoma:
EA cells by electron microscopy (EM) also proves to be helpful A literature review of a rare entity in an unusual site. Gynecol
in the diagnosis of these tumors. Classic findings on EM include Oncol Rep. 2021;36:100706. Published 2021 Jan 21. doi:10.1016/j.
presence of pinocytotic vesicles, presence of red blood cells gore.2021.100706
in vascular channels, presence of Weibel-Palade bodies, and 3. Avancini J, Sanches JA, Cherubim AP, et al. Angiosarcoma in HIV-
desmosome attachments [23]. negative patients is not associated with HHV-8. An Bras Dermatol.
2016;91(6):738-741. doi:10.1590/abd1806-4841.20164730
Immunohistochemistry (IHC) is immensely supportive in
diagnosing EA.4 Vimentin is almost always positive in EA, as it 4. Wu J, Li X, Liu X. Epithelioid angiosarcoma: a clinicopathological
is a marker for mesenchymal differentiation. The most sensitive study of 16 Chinese cases. Int J Clin Exp Pathol. 2015;8(4):3901-3909.
Published 2015 Apr 1.
markers for EA include CD31 and Fli-1, though less sensitive
makers such as CD34 and Factor VIII-related antigen may also 5. Weiss SW, Ishak KG, Dail DH, Sweet DE, Enzinger FM. Epithelioid
be useful in identifying endothelial cells [4,12]. Advances of hemangioendothelioma and related lesions. Semin Diagn Pathol. 1986
surgical pathology techniques as well as further development Nov;3(4):259-87. PMID: 3303234.
of immunohistochemistry have enabled the recognition of 6. Li C, Chen Y, Zhang H, Zheng X, Wang J. Epithelioid angiosarcoma
malignant sarcomas with epithelioid cells since the original arising in schwannoma: report of three Chinese cases with review of
description in 1986 [5]. the literature. Pathol Int. 2012;62(7):500-505. doi:10.1111/j.1440-
1827.2012.02827.x
The current standard of care includes surgery, radiotherapy
7. Wenger DE, Wold LE. Malignant vascular lesions of bone: radiologic
or chemotherapy, or a combination of the three. Paclitaxel-
and pathologic features. Skeletal Radiol. 2000;29(11):619-631.
based chemotherapy has been shown to improve survival [24]. doi:10.1007/s002560000261
Neoadjuvant combination of radiation therapy and Bevacizumab
8. Branch, K Drake MD; Smith, M Timothy MD Epithelioid Angiosarcoma,
is being studied as a potentially modality prior to surgical
Pathology Case Reviews: November 2008 - Volume 13 - Issue 6 - p
intervention [25]. Wide excision is recommended, when possible, 264-268 doi: 10.1097/PCR.0b013e31818bb9b9
though the head and neck area is a relatively complex small space
to achieve negative margins. The possibility of adjuvant therapy 9. Suchak R, Thway K, Zelger B, Fisher C, Calonje E. Primary cutaneous
epithelioid angiosarcoma: a clinicopathologic study of 13 cases
is determined on an individual basis [9].
of a rare neoplasm occurring outside the setting of conventional
Prognosis of angiosarcoma is dependent on primary tumor angiosarcomas and with predilection for the limbs [published
site, size, mitotic activity, stage and cellularity. Poor prognostic correction appears in Am J Surg Pathol. 2011 Apr;35(4):619]. Am J
Surg Pathol. 2011;35(1):60-69. doi:10.1097/PAS.0b013e3181fee87
factors include lesions larger than 5 centimeters in size and
bleeding [22]. Generally, EAs have a poor prognosis due to the 10. Meis-Kindblom JM, Kindblom LG. Angiosarcoma of soft tissue:
ability to grow quickly and metastasize to brain, bone, lung, a study of 80 cases. Am J Surg Pathol. 1998;22(6):683-697.
lymph nodes and soft tissue [23]. The prognosis of angiosarcoma doi:10.1097/00000478-199806000-00005

SM J Sarcoma Res 5: 4 3/4


11. Young RJ, Brown NJ, Reed MW, Hughes D, Woll PJ. Angiosarcoma. 20. Penel N, Marréaud S, Robin YM, Hohenberger P. Angiosarcoma: state
Lancet Oncol. 2010;11(10):983-991. doi:10.1016/S1470- of the art and perspectives. Crit Rev Oncol Hematol. 2011;80(2):257-
2045(10)70023-1 263. doi:10.1016/j.critrevonc.2010.10.007

12. Gaballah AH, Jensen CT, Palmquist S, et al. Angiosarcoma: 21. Okada E M.D, Matsumoto M M.D, Nishida M, et al. Epithelioid
clinical and imaging features from head to toe. Br J Radiol. Hemangioma of the Thoracic Spine: A Case Report and Review of the
2017;90(1075):20170039. doi:10.1259/bjr.20170039 Literature. J Spinal Cord Med. 2019;42(6):800-805. doi:10.1080/107
90268.2017.1390032
13. Razek AA, Huang BY. Soft tissue tumors of the head and neck:
imaging-based review of the WHO classification. Radiographics. 22. Sundaram M, Vetrichevvel TP, Subramanyam S, Subramaniam A.
2011;31(7):1923-1954. doi:10.1148/rg.317115095 Primary multicentric cutaneous epithelioid angiosarcoma.  Indian
J Dermatol Venereol Leprol. 2011;77(1):111. doi:10.4103/0378-
14. Walker EA, Salesky JS, Fenton ME, Murphey MD. Magnetic resonance 6323.74990
imaging of malignant soft tissue neoplasms in the adult. Radiol Clin
North Am. 2011;49(6):1219-vi. doi:10.1016/j.rcl.2011.07.006 23. Hart J, Mandavilli S. Epithelioid angiosarcoma: a brief diagnostic review
and differential diagnosis.  Arch Pathol Lab Med. 2011;135(2):268-
15. Chang JH, Kim JH, Hong SH, et al. Angiosarcoma presenting with 272. doi:10.5858/135.2.268
spontaneous hydropneumothorax: report of a case and review of the
literature. Open Respir Med J. 2014;8:48-54. Published 2014 Dec 26. 24. Fata F, O’Reilly E, Ilson D, et al. Paclitaxel in the treatment of patients
doi:10.2174/1874306401408010048. with angiosarcoma of the scalp or face.  Cancer. 1999;86(10):2034-
2037.
16. Almogy G, Lieberman S, Gips M, et al. Clinical outcomes of surgical
resections for primary liver sarcoma in adults: results from a single 25. Koontz BF, Miles EF, Rubio MA, et al. Preoperative radiotherapy
centre. Eur J Surg Oncol. 2004;30(4):421-427. doi:10.1016/j. and bevacizumab for angiosarcoma of the head and neck: two case
ejso.2004.01.004 studies. Head Neck. 2008;30(2):262-266. doi:10.1002/hed.20674

17. Murinello A, Mendonça P, Abreu A, et al. Cardiac angiosarcoma--a 26. Breiteneder-Geleff S, Soleiman A, Kowalski H, et al. Angiosarcomas
review. Rev Port Cardiol. 2007;26(5):577-584. express mixed endothelial phenotypes of blood and lymphatic
capillaries: podoplanin as a specific marker for lymphatic
18. Allison KH, Yoder BJ, Bronner MP, Goldblum JR, Rubin BP. endothelium. Am J Pathol. 1999;154(2):385-394. doi:10.1016/S0002-
Angiosarcoma involving the gastrointestinal tract: a series of 9440(10)65285-6
primary and metastatic cases. Am J Surg Pathol. 2004;28(3):298-307.
doi:10.1097/00000478-200403000-00002 27. Gao Y, Warshaw H, Singtong B, Polan-Couillard L, Aziz M, et al.
(2021). Proximal-Type Epithelioid Sarcoma. A case Report of a Rare
19. Scott MT, Portnow LH, Morris CG, et al. Radiation therapy for Tumor with Challenging Diagnosis and Review of the Literature. SM
angiosarcoma: the 35-year University of Florida experience. Am J Clin J Sarcoma Res 5: 4.
Oncol. 2013;36(2):174-180. doi:10.1097/COC.0b013e3182436ea3

SM J Sarcoma Res 5: 4 4/4

You might also like